Localization and upregulation of survivin in cancer health disparities: a clinical perspective

References

• SiegelRNaishadhamDJemalACancer statistics, 2013CA Cancer J Clin2013631113023335087
   PubMed Web of Science ®Google Scholar
• SharpLDeadySGallagherPThe magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship careBMC Cancer20141476725319534
   PubMed Web of Science ®Google Scholar
• JadavSRajanSSAbughoshSSansgirySSThe role of socioeconomic status and health care access in breast cancer screening compliance among HispanicsJ Public Health Manag Pract Epub392015
   Web of Science ®Google Scholar
• BeydounHABeydounMAPredictors of colorectal cancer screening behaviors among average-risk older adults in the United StatesCancer Causes Control200819433935918085415
   PubMed Web of Science ®Google Scholar
• GuessousIDashCLapinPDoroshenkMSmithRAKlabundeCNNational Colorectal Cancer Roundtable Screening Among the 65 Plus Task GroupColorectal cancer screening barriers and facilitators in older personsPrev Med2010501–231020006644
   PubMed Web of Science ®Google Scholar
• TsaiCJGiovannucciELHyperinsulinemia, insulin resistance, vitamin D, and colorectal cancer among whites and African AmericansDig Dis Sci201257102497250322562539
   PubMed Web of Science ®Google Scholar
• PalmerSDiet, nutrition and cancerProg Food Nutr Sci198593–42833413010379
   PubMedGoogle Scholar
• TakachiRTsubonoYBabaKRed meat intake may increase the risk of colon cancer in Japanese, a population with relatively low red meat consumptionAsia Pac J Clin Nutr201120460361222094846
   PubMed Web of Science ®Google Scholar
• KonoSHost and environmental factors predisposing to cancer developmentGan To Kagaku Ryoho2010374571576 Japanese20414009
   PubMedGoogle Scholar
• KasugaMUekiKTajimaNReport of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and CancerCancer Sci2013104796597623879470
   PubMed Web of Science ®Google Scholar
• GuthrieNCarrollKKSpecific versus non-specific effects of dietary fat on carcinogenesisProg Lipid Res199938326127110664796
   PubMed Web of Science ®Google Scholar
• NakamuraKNagataCWadaKCigarette smoking and other lifestyle factors in relation to the risk of pancreatic cancer death: a prospective cohort study in JapanJpn J Clin Oncol201141222523121075833
   PubMed Web of Science ®Google Scholar
• De PergolaGSilvestrisFObesity as a major risk factor for cancerJ Obes2013201329154624073332
   PubMedGoogle Scholar
• ReedJCThe Survivin saga goes in vivoJ Clin Invest2001108796596911581297
   PubMed Web of Science ®Google Scholar
• LiFAmbrosiniGChuEYControl of apoptosis and mitotic spindle checkpoint by survivinNature199839667115805849859993
   PubMed Web of Science ®Google Scholar
• AndersenMHSvaneIMBeckerJCStratenPTThe universal character of the tumor-associated antigen survivinClin Cancer Res200713205991599417947459
   PubMed Web of Science ®Google Scholar
• AltieriDCSurvivin, versatile modulation of cell division and apoptosis in cancerOncogene200322538581858914634620
   PubMed Web of Science ®Google Scholar
• AltieriDCThe case for survivin as a regulator of microtubule dynamics and cell death decisionsCurr Opin Cell Biol200618660961516934447
   PubMed Web of Science ®Google Scholar
• DohiTBeltramiEWallNRPlesciaJAltieriDCMitochondrial survivin inhibits apoptosis and promotes tumorigenesisJ Clin Invest200411481117112715489959
   PubMed Web of Science ®Google Scholar
• FortugnoPWallNRGiodiniASurvivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule functionJ Cell Sci2002115Pt 357558511861764
   PubMed Web of Science ®Google Scholar
• KhanSAspeJRAsumenMGExtracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potentialBr J Cancer200910071073108619293795
   PubMed Web of Science ®Google Scholar
• KhanSJutzyJMAspeJRMcGregorDWNeidighJWWallNRSurvivin is released from cancer cells via exosomesApoptosis201116111220717727
   PubMed Web of Science ®Google Scholar
• WebberJYeungVClaytonAExtracellular vesicles as modulators of the cancer microenvironmentSemin Cell Dev Biol201540273425662446
   PubMed Web of Science ®Google Scholar
• LiFAckermannEJBennettCFPleiotropic cell-division defects and apoptosis induced by interference with survivin functionNat Cell Biol19991846146610587640
   PubMed Web of Science ®Google Scholar
• LiFLingXSurvivin study: an update of “what is the next wave”?J Cell Physiol2006208347648616557517
   PubMed Web of Science ®Google Scholar
• YangDWelmABishopJMCell division and cell survival in the absence of survivinProc Natl Acad Sci U S A200410142151001510515477601
   PubMed Web of Science ®Google Scholar
• ChurchDNTalbotDCSurvivin in solid tumors: rationale for development of inhibitorsCurr Oncol Rep201214212012822234703
   PubMed Web of Science ®Google Scholar
• AltieriDCSurvivin, cancer networks and pathway-directed drug discoveryNat Rev Cancer200881617018075512
   PubMed Web of Science ®Google Scholar
• DongZVenkatachalamMAWangJUp-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanismsJ Biol Chem200127622187021870911278985
   PubMed Web of Science ®Google Scholar
• DohiTOkadaKXiaFAn IAP-IAP complex inhibits apoptosisJ Biol Chem200427933340873409015218035
   PubMed Web of Science ®Google Scholar
• ZagórskaADulakJHIF-1: the knowns and unknowns of hypoxia sensingActa Biochim Pol200451356358515448722
   PubMed Web of Science ®Google Scholar
• TammIWangYSausvilleEIAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugsCancer Res19985823531553209850056
   PubMed Web of Science ®Google Scholar
• BanksDPPlesciaJAltieriDCSurvivin does not inhibit caspase-3 activityBlood200096124002400311186274
   PubMed Web of Science ®Google Scholar
• MarusawaHMatsuzawaSWelshKHBXIP functions as a cofactor of survivin in apoptosis suppressionEMBO J200322112729274012773388
   PubMed Web of Science ®Google Scholar
• DenzerKKleijmeerMJHeijnenHFStoorvogelWGeuzeHJExosome: from internal vesicle of the multivesicular body to intercellular signaling deviceJ Cell Sci2000113Pt 193365337410984428
   PubMed Web of Science ®Google Scholar
• KellerSSandersonMPStoeckAAltevogtPExosomes: from biogenesis and secretion to biological functionImmunol Lett2006107210210817067686
   PubMed Web of Science ®Google Scholar
• SimpsonRJLimJWMoritzRLMathivananSExosomes: proteomic insights and diagnostic potentialExpert Rev Proteomics20096326728319489699
   PubMed Web of Science ®Google Scholar
• GreeningDWGopalSKXuRSimpsonRJChenWExosomes and their roles in immune regulation and cancerSemin Cell Dev Biol201540728125724562
   PubMed Web of Science ®Google Scholar
• WolfersJLozierARaposoGTumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-primingNat Med20017329730311231627
   PubMed Web of Science ®Google Scholar
• AndreFSchartzNEMovassaghMMalignant effusions and immunogenic tumour-derived exosomesLancet2002360932929530512147373
   PubMed Web of Science ®Google Scholar
• WieckowskiEWhitesideTLHuman tumor-derived vs dendritic cell-derived exosomes have distinct biologic roles and molecular profilesImmunol Res2006361–324725417337785
   PubMed Web of Science ®Google Scholar
• ZitvogelLRegnaultALozierAEradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomesNat Med1998455946009585234
   PubMed Web of Science ®Google Scholar
• AlečkovićMKangYRegulation of cancer metastasis by cell-free miRNAsBiochim Biophys Acta201518551244225450578
   PubMed Web of Science ®Google Scholar
• AltieriDCValidating survivin as a cancer therapeutic targetNat Rev Cancer200331465412509766
   PubMed Web of Science ®Google Scholar
• GinestraALa PlacaMDSaladinoFCassaràDNagaseHVittorelliMLThe amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasivenessAnticancer Res1998185A343334379858920
   PubMed Web of Science ®Google Scholar
• GinestraAMiceliDDoloVRomanoFMVittorelliMLMembrane vesicles in ovarian cancer fluids: a new potential markerAnticancer Res1999194C3439344510629632
   PubMed Web of Science ®Google Scholar
• NilssonJSkogJNordstrandAProstate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancerBr J Cancer2009100101603160719401683
   PubMed Web of Science ®Google Scholar
• RolfoCCastigliaMHongDLiquid biopsies in lung cancer: the new ambrosia of researchersBiochim Biophys Acta20141846253954625444714
   PubMed Web of Science ®Google Scholar
• AdamsMNavabiHCrostonDThe rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancerVaccine20052317–182374237815755631
   PubMed Web of Science ®Google Scholar
• ShenderVOPavlyukovMSZiganshinRHProteome-metabolome profiling of ovarian cancer ascites reveals novel components involved in intercellular communicationMol Cell Proteomics201413123558357125271300
   PubMed Web of Science ®Google Scholar
• ParkJOChoiDYChoiDSIdentification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusionsProteomics201313142125213423585444
   PubMed Web of Science ®Google Scholar
• KhanSJutzyJMValenzuelaMMPlasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancerPLoS One2012710e4673723091600
   PubMed Web of Science ®Google Scholar
• Zangemeister-WittkeUSimonHUAn IAP in action: the multiple roles of survivin in differentiation, immunity and malignancyCell Cycle2004391121112315326382
   PubMed Web of Science ®Google Scholar
• XingZConwayEMKangCWinotoAEssential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasisJ Exp Med20041991698014699085
   PubMed Web of Science ®Google Scholar
• MeraSMagnussonMTarkowskiABokarewaMExtracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity patternJ Leukoc Biol200883114915517938276
   PubMed Web of Science ®Google Scholar
• TanakaMButlerMOAnsénSInduction of HLA-DP4-restricted anti-survivin Th1 and Th2 responses using an artificial antigen-presenting cellClin Cancer Res201117165392540121705450
   PubMed Web of Science ®Google Scholar
• YangZWangLWangHA novel mimovirus vaccine containing survivin epitope with adjuvant IL-15 induces long-lasting cellular immunity and high antitumor efficiencyMol Immunol20084561674168118035418
   PubMed Web of Science ®Google Scholar
• LladserAPárragaMQuevedoLNaked DNA immunization as an approach to target the generic tumor antigen survivin induces humoral and cellular immune responses in miceImmunobiology20062111–2112716446167
   PubMed Web of Science ®Google Scholar
• WanYYMulti-tasking of helper T cellsImmunology2010130216617120557575
   PubMed Web of Science ®Google Scholar
• PietraGManziniCRivaraSMelanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activityCancer Res20127261407141522258454
   PubMed Web of Science ®Google Scholar
• AmarnathSMaqusCWWangJCThe PDL1-PD1 axis converts human TH1 cells into regulatory T cellsSci Transl Med20113111111ra120
   PubMed Web of Science ®Google Scholar
• JutzyJMKhanSAsuncion-ValenzuelaMMMilfordTAPayneKJWallNRTumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitroCancer Microenviron201361576822322461
   PubMedGoogle Scholar
• DehalAAbbasAJohnaSRacial disparities in clinical presentation, surgical treatment and in-hospital outcomes of women with breast cancer: analysis of nationwide inpatient sample databaseBreast Cancer Res Treat2013139256156923690143
   PubMed Web of Science ®Google Scholar
• JohnsonRHChienFLBleyerAIncidence of breast cancer with distant involvement among women in the United States, 1976 to 2009JAMA2013309880080523443443
   PubMed Web of Science ®Google Scholar
• VelculescuVEMaddenSLZhangLAnalysis of human transcriptomesNat Genet199923438738810581018
   PubMed Web of Science ®Google Scholar
• Kalla SinghSTanQWBritoCDe LeónMGarberoglioCDe LeónDDifferential insulin-like growth factor II (IGF-II) expression: A potential role for breast cancer survival disparityGrowth Horm IGF Res201020216217020089431
   PubMed Web of Science ®Google Scholar
• AdamkovMKajoKVybohovaDKrajcovicJStullerFRajcaniJCorrelations of survivin expression with clinicomorphological parameters and hormonal receptor status in breast ductal carcinomaNeoplasma2012591303722103896
   PubMed Web of Science ®Google Scholar
• RexhepajEJirstromKO’ConnorDPValidation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancerBMC Cancer20101063921092276
   PubMed Web of Science ®Google Scholar
• XuCYamamoto-IbusukiMYamamotoYHigh survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein levelBreast Cancer201421448249022968628
   PubMed Web of Science ®Google Scholar
• Dedić PlavetićNJakić-RazumovićJKulićAVrbanecDPrognostic value of proliferation markers expression in breast cancerMed Oncol201330252323468220
   PubMed Web of Science ®Google Scholar
• SpanPNTjan-HeijnenVCMandersPvan TienovenDLehrJSweepFCHigh survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancerBreast Cancer Res Treat200698222323016541327
   PubMed Web of Science ®Google Scholar
• LiFRole of survivin and its splice variants in tumorigenesisBr J Cancer200592221221615611788
   PubMed Web of Science ®Google Scholar
• Necochea-CampionRdChenCSMirshahidiSHowardFDWallNRClinico-pathologic relevance of Survivin splice variant expression in cancerCancer Lett2013339216717423791888
   PubMed Web of Science ®Google Scholar
• BoidotRVegranFLizard-NacolSPredictive value of survivin alternative transcript expression in locally advanced breast cancer patients treated with neoadjuvant chemotherapyInt J Mol Med200923228529119148555
   PubMed Web of Science ®Google Scholar
• KhanSBennitHFTurayDEarly diagnostic value of survivin and its alternative splice variants in breast cancerBMC Cancer20141417624620748
   PubMed Web of Science ®Google Scholar
• BrawleyOWProstate cancer epidemiology in the United StatesWorld J Urol201230219520022476558
   PubMed Web of Science ®Google Scholar
• BasuABanerjeeHRojasHDifferential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4Prostate201171775576521031435
   PubMed Web of Science ®Google Scholar
• HoffmanRMGillilandFDEleyJWRacial and ethnic differences in advanced-stage prostate cancer: the Prostate Cancer Outcomes StudyJ Natl Cancer Inst200193538839511238701
   PubMed Web of Science ®Google Scholar
• KaramiSYoungHAHensonDEEarlier age at diagnosis: another dimension in cancer disparity?Cancer Detect Prev2007311293417303347
   PubMedGoogle Scholar
• ZaffaroniNPennatiMDaidoneMGSurvivin as a target for new anticancer interventionsJ Cell Mol Med20059236037215963255
   PubMed Web of Science ®Google Scholar
• ShariatSFLotanYSaboorianHSurvivin expression is associated with features of biologically aggressive prostate carcinomaCancer2004100475175714770431
   PubMed Web of Science ®Google Scholar
• KoikeHSekineYKamiyaMNakazatoHSuzukiKGene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancerUrology20087261229123318336887
   PubMed Web of Science ®Google Scholar
• ZhangMHoAHammondEHPrognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610Int J Radiat Oncol Biol Phys20097341033104218977097
   PubMed Web of Science ®Google Scholar
• LowenfelsABMaisonneuvePEpidemiology and risk factors for pancreatic cancerBest Pract Res Clin Gastroenterol200620219720916549324
   PubMed Web of Science ®Google Scholar
• GordisLGoldEBEpidemiology and Etiology of Pancreatic CancerGoPancreas, Biology, and Pathobiology of Disease Second EditionNew YorkRaven Press1993837855
   Google Scholar
• WoutersenRAAppelMJvan Garderen-HoetmerAWijnandsMVDietary fat and carcinogenesisMutat Res19994431–211112710415435
   PubMed Web of Science ®Google Scholar
• SingalVSingalAKKuoYFRacial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysisJ Cancer Res Clin Oncol2012138471572222246279
   PubMed Web of Science ®Google Scholar
• HayangaAJRisk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groupsCancer20051041125302531 author reply 253116240447
   PubMed Web of Science ®Google Scholar
• ChangKJParasherGChristieCLargentJAnton-CulverHRisk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groupsCancer2005103234935715593353
   PubMed Web of Science ®Google Scholar
• PernickNLSarkarFHPhilipPAClinicopathologic analysis of pancreatic adenocarcinoma in African Americans and CaucasiansPancreas2003261283212499914
   PubMed Web of Science ®Google Scholar
• DingXZTongWGAdrianTECyclooxygenases and lipoxygenases as potential targets for treatment of pancreatic cancerPancreatology20011429129912120207
   PubMed Web of Science ®Google Scholar
• TongWGDingXZWittRCAdrianTELipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathwayMol Cancer Ther200211192993512481414
   PubMed Web of Science ®Google Scholar
• XieHJiangWXiaoSYLiuXHigh expression of survivin is prognostic of shorter survival but not predictive of adjuvant gemcitabine benefit in patients with resected pancreatic adenocarcinomaJ Histochem Cytochem201361214815523124118
   PubMed Web of Science ®Google Scholar
• ToniniGVincenziBSantiniDNuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patientsBr J Cancer200592122225223215928668
   PubMed Web of Science ®Google Scholar
• SagolOYavuzsenTOztopIThe effect of apoptotic activity, survivin, Ki-67, and P-glycoprotein expression on prognosis in pancreatic carcinomaPancreas200530434334815841045
   PubMed Web of Science ®Google Scholar
• SunHCQiuZJLiuJExpression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosisInt J Oncol20073061359136717487356
   PubMed Web of Science ®Google Scholar
• The Leukemia and Lymphoma Society [webpage on the Internet]Facts and statisticsWhite Plains, NYThe Leukemia and Lymphoma Society2015 Available from: http://www.lls.org/diseaseinformation/getinformationsupport/factsstatistics/Accessed February 15, 2015
   Google Scholar
• PulteDRedanielMTBrennerHJeffreysMChanges in survival by ethnicity of patients with cancer between 1992–1996 and 2002–2006: is the discrepancy decreasing?Ann Oncol20122392428243422396445
   PubMed Web of Science ®Google Scholar
• Waligórska-StachuraJJankowskaAWaśkoRSurvivin – prognostic tumor biomarker in human neoplasms – reviewGinekol Pol201283753754022880480
   PubMed Web of Science ®Google Scholar
• FuldaSInhibitor of apoptosis proteins in hematological malignanciesLeukemia200923346747619039324
   PubMed Web of Science ®Google Scholar
• FuldaSExploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignanciesLeukemia20122661155116522230799
   PubMed Web of Science ®Google Scholar
• KamihiraSYamadaYHirakataYAberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosisBr J Haematol20011141636911472346
   PubMed Web of Science ®Google Scholar
• AdidaCRecherCRaffouxEExpression and prognostic significance of survivin in de novo acute myeloid leukaemiaBr J Haematol2000111119620311091201
   PubMed Web of Science ®Google Scholar
• ParkEGangEJHsiehYTTargeting survivin overcomes drug resistance in acute lymphoblastic leukemiaBlood201111882191219921715311
   PubMed Web of Science ®Google Scholar
• KellyRJLopez-ChavezACitrinDJanikJEMorrisJCImpacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivinMol Cancer2011103521470426
   PubMed Web of Science ®Google Scholar
• TroegerASiepermannMEscherichGSurvivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemiaHaematologica20079281043105017640858
   PubMed Web of Science ®Google Scholar
• EshAMAtfyMAziziNAEl NaggarMMKhalilEESheriefLPrognostic significance of survivin in pediatric acute lymphoblastic leukemiaIndian J Hematol Blood Transfus2011271182522379290
   PubMed Web of Science ®Google Scholar
• TynerJWJemalAMThayerMDrukerBJChangBHTargeting survivin and p53 in pediatric acute lymphoblastic leukemiaLeukemia201226462363221960246
   PubMed Web of Science ®Google Scholar
• AhmedMBShehataHHMoussaMIbrahimTMPrognostic significance of survivin and tumor necrosis factor-alpha in adult acute lymphoblastic leukemiaClin Biochem2012451–211211621933669
   PubMed Web of Science ®Google Scholar
• MorrisonDJHoganLECondosGEndogenous knockdown of survivin improves chemotherapeutic response in ALL modelsLeukemia201226227127921844871
   PubMed Web of Science ®Google Scholar
• WangZSampathJFukudaSPelusLMDisruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosisCancer Res200565188224823216166298
   PubMed Web of Science ®Google Scholar
• Grzybowska-IzydorczykOCebulaBRobakTSmolewskiPExpression and prognostic significance of the inhibitor of apoptosis protein (IAP) family and its antagonists in chronic lymphocytic leukaemiaEur J Cancer201046480081020045309
   PubMed Web of Science ®Google Scholar
• CarterBZQiuYHuangXSurvivin is highly expressed in CD34(+)38(−) leukemic stem/progenitor cells and predicts poor clinical outcomes in AMLBlood2012120117318022645176
   PubMed Web of Science ®Google Scholar
• SmallSKeerthivasanGHuangZGurbuxaniSCrispinoJDOverexpression of survivin initiates hematologic malignancies in vivoLeukemia201024111920192620882051
   PubMed Web of Science ®Google Scholar
• KumarBYadavALangJCYM155 reverses cisplatin resistance in head and neck cancer by decreasing cytoplasmic survivin levelsMol Cancer Ther20121191988199822723337
   PubMed Web of Science ®Google Scholar
• BernardoPSReisFRMaiaRCImatinib increases apoptosis index through modulation of survivin subcellular localization in the blast phase of CML cellsLeuk Res201236121510151622975581
   PubMed Web of Science ®Google Scholar
• QinQZhangCZhuHAssociation between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studiesJ Cancer Res Clin Oncol2014140217918824077840
   PubMed Web of Science ®Google Scholar
• Radojevic-SkodricSBasta-JovanovicGBrasanacDSurvivin gene promoter −31 G/C polymorphism is associated with Wilms tumor susceptibility in Serbian childrenJ Pediatr Hematol Oncol2012348e310e31422858571
   PubMed Web of Science ®Google Scholar
• LiFYangJRamnathNJavleMMTanDNuclear or cytoplasmic expression of survivin: what is the significance?Int J Cancer2005114450951215578717
   PubMed Web of Science ®Google Scholar